Memorial Day! 45% Off Premium Subscription Claim Offer ⏰ 0d 00h 00m 00s

Brainstorm Cell Therapeutics. Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 76.47. In total, the insiders bought 3 550 401 and sold 159 753 BCLI shares in the last 100 trades.

Insider Power

(Last 100 transactions)
76.47
Buy 3 550 401 Shares
Sell 159 753 Shares

Historical Insider Trades

Date Type Action Person Amount
Jan 01, 2025 Common Stock Buy Dagher Ibrahim B. 50 000
Jan 01, 2025 Common Stock Buy Lebovits Chaim 120 000
Jan 01, 2025 Common Stock Buy Frenkel Jacob A 40 000
Jan 01, 2025 Common Stock Buy Polverino Anthony J. 24 000
Jan 01, 2025 Common Stock Buy Yablonka Uri 20 000
Jan 01, 2025 Common Stock Buy Yablonka Uri 40 000
Jan 01, 2025 Common Stock Buy Patlis Alla 40 000
Jan 01, 2025 Common Stock Buy Naor Nir 30 666
Jan 01, 2025 Common Stock Buy Lindborg Stacy 20 000
Jan 01, 2025 Common Stock Buy Hartounian Hartoun 50 000
Jan 01, 2025 Common Stock Buy Bairu Menghisteab 24 000
Jan 01, 2025 Common Stock Buy Arbel Irit 30 666
Oct 01, 2024 Common Stock Buy Lebovits Chaim 1 836
Sep 30, 2024 Common Stock Buy Lebovits Chaim 22 000
Jul 19, 2024 Common Stock Sell Dagher Ibrahim B. 63 000
Jun 24, 2024 Stock Option (Right to Buy) Buy Hartounian Hartoun 60 000
Jun 24, 2024 Common Stock Buy Hartounian Hartoun 30 000
Jun 24, 2024 Buy Hartounian Hartoun 0
May 28, 2024 Common Stock Buy Lebovits Chaim 15 000
May 28, 2024 Common Stock Buy Lebovits Chaim 15 000
May 22, 2024 Common Stock Buy Lebovits Chaim 25 000
May 22, 2024 Common Stock Buy Lebovits Chaim 25 000
May 21, 2024 Common Stock Buy Lebovits Chaim 25 000
May 21, 2024 Common Stock Buy Lebovits Chaim 25 000
May 13, 2024 Common Stock Buy Lebovits Chaim 10 000
Click to get the best stock tips daily for free!
ABOUT BRAINSTORM CELL THERAPEUTICS INC.
Brainstorm Cell Therapeutics.
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative ...
GOLDEN STAR
Ticker Change Signal Date
UAA
$5.84
14.55% May 09
HBM
$7.41
18.89% May 05
PODD
$257.01
25.04% May 02
GT
$9.14
19.80% Mar 21
O
ODD
$44.71
55.78% Mar 13

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE